Atypical protein kinase C ζ exhibits a proapoptotic function in ovarian cancer

Molecular Cancer Research

Volumn 8, Issue 6, 2010, Pages 919-934

  Nazarenko, Irina ^a   Jenny, Marcel ^b   Keil, Jana ^a   Gieseler, Cornelia ^a   Weisshaupt, Karen ^a   Sehouli, Jalid ^a   Legewie, Stefan ^a   Herbst, Lena ^a   Weichert, Wilko ^a   Darb Esfahani, Silvia ^a   Dietel, Manfred ^a   Schäfer, Reinhold ^a   Ueberall, Florian ^b   Sers, Christine ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; GEFITINIB; OKADAIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN HRSL3; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C IOTA; PROTEIN KINASE C THETA; PROTEIN KINASE C ZETA; TUMOR SUPPRESSOR PROTEIN; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HUMANS; ISOENZYMES; OKADAIC ACID; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROTEIN KINASE C; TUMOR MARKERS, BIOLOGICAL;

EID: 77953790111     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0358     Document Type: Article

References (72)

1. Weinstein IB. Growth factors, oncogenes, and multistage carcinogenesis. J Cell Biochem 1987;33:213-24.
2. Breitkreutz D, Braiman-Wiksman L, Daum N, Denning MF, Tennenbaum T. Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium. J Cancer Res Clin Oncol 2007;133:793-808.
3. Nicosia SV, Bai W, Cheng JQ, Coppola D, Kruk PA. Oncogenic pathways implicated in ovarian epithelial cancer. Hematol Oncol Clin North Am 2003;17:927-43.
4. McCubrey JA, Steelman LS, Franklin RA, et al. Targeting the RAF/ MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance. Adv Enzyme Regul 2007;47:64-103.
5. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007; 26:3291-310.
6. Parker PJ, Murray-Rust J. PKC at a glance. J Cell Sci 2004;117: 131-2.
7. Mackay HJ, Twelves CJ. Targeting the protein kinase C family: Are we there yet? Nat Rev Cancer 2007;7:554-62.
8. Shayesteh L, Lu Y, Kuo WL, et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999;21:99-102.
9. Yin L, Bennani-Baiti N, Powell CT. Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway. J Biol Chem 2005;280:5533-41.
10. Moscat J, Rennert P, Diaz-Meco MT. PKCζ at the crossroad of NF-κB and Jak1/Stat6 signaling pathways. Cell Death Differ 2006;13:702-11.
11. Martin P, Duran A, Minguet S, et al. Role of ζ PKC in B-cell signaling and function. EMBO J 2002;21:4049-57.
12. Leitges M, Sanz L, Martin P, et al. Targeted disruption of the ζPKC gene results in the impairment of the NF-κB pathway. Mol Cell 2001; 8:771-80.
13. Slosberg ED, Klein MG, Yao Y, Han EK, Schieren I, Weinstein IB. The α isoform of protein kinase C mediates phorbol ester-induced growth inhibition and p21cip1 induction in HC11 mammary epithelial cells. Oncogene 1999;18:6658-66.
14. Detjen KM, Brembeck FH, Welzel M, et al. Activation of protein kinase Cα inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest. J Cell Sci 2000;113:3025-35.
15. Weichert W, Gekeler V, Denkert C, Dietel M, Hauptmann S. Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis. Int J Oncol 2003;23:633-9.
16. Jiang XH, Tu SP, Cui JT, et al. Antisense targeting protein kinase C α and β1 inhibits gastric carcinogenesis. Cancer Res 2004;64: 5787-94.
17. Zhang L, Huang J, Yang N, et al. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCI as a biomarker and potential oncogene in ovarian carcinoma. Cancer Res 2006;66: 4627-35.
18. Murray NR, Weems J, Braun U, Leitges M, Fields AP. Protein kinase C βII and PKCI/λ: collaborating partners in colon cancer promotion and progression. Cancer Res 2009;69:656-62.
19. Nazarenko I, Schafer R, Sers C. Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells. J Cell Sci 2007; 120:1393-404.
20. Sers C, Husmann K, Nazarenko I, et al. The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNγ-induced cell death in human ovarian carcinoma cells. Oncogene 2002;21:2829-39.
21. Hajnal A, Klemenz R, Schafer R. Subtraction cloning of H-Rev107, a gene specifically expressed in H-Ras resistant fibroblasts. Oncogene 1994;9:479-90. (Pubitemid 24041527)
22. Kampfer S, Hellbert K, Villunger A, et al. Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-λ, ε and ζ. EMBO J 1998; 17:4046-55.
23. Lavrik IN, Mock T, Golks A, Hoffmann JC, Baumann S, Krammer PH. CD95 stimulation results in the formation of a novel death effector domain protein-containing complex. J Biol Chem 2008;283: 26401-8.
24. Uberall F, Hellbert K, Kampfer S, et al. Evidence that atypical protein kinase C-λ and atypical protein kinase C-ζ participate in Ras-mediated reorganization of the F-actin cytoskeleton. J Cell Biol 1999;144:413-25.
25. Hemmati PG, Gillissen B, von Haefen C, et al. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Oncogene 2002;21:3149-61.
26. Liang X, Reed E, Yu JJ. Protein phosphatase 2A interacts with Chk2 and regulates phosphorylation at Thr-68 after cisplatin treatment of human ovarian cancer cells. Int J Mol Med 2006;17: 703-8.
27. Noske A, Weichert W, Niesporek S, et al. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer. Cancer 2008;112: 1733-43.
28. Mills GB, Lu Y, Fang X, et al. The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy. Semin Oncol 2001; 28:125-41.
29. Boudreau RT, Conrad DM, Hoskin DW. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase. Cell Signal 2007;19:139-51.
30. Chen W, Possemato R, Campbell KT, Plattner CA, Pallas DC, Hahn WC. Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 2004;5:127-36.
31. Chen W, Arroyo JD, Timmons JC, Possemato R, Hahn WC. Cancer-associated PP2A Aα subunits induce functional haploinsufficiency and tumorigenicity. Cancer Res 2005;65:8183-92.
32. Gysin S, Imber R. Phorbol-ester-activated protein kinase C-α lacking phosphorylation at Ser657 is down-regulated by a mechanism involving dephosphorylation. Eur J Biochem 1997;249: 156-60. (Pubitemid 27432609)
33. Gysin S, Imber R. Replacement of Ser657 of protein kinase C-α by alanine leads to premature down regulation after phorbol-ester-induced translocation to the membrane. Eur J Biochem 1996;240:747-50. (Pubitemid 26321180)
34. Parekh DB, Ziegler W, Parker PJ. Multiple pathways control protein kinase C phosphorylation. EMBO J 2000;19:496-503. (Pubitemid 30093722)
35. Housey GM, Johnson MD, Hsiao WL, O'Brian CA, Weinstein IB. Structural and functional studies of protein kinase C. Adv Exp Med Biol 1988;234:127-40.
36. Anantharam V, Kitazawa M, Wagner J, Kaul S, Kanthasamy AG. Caspase-3-dependent proteolytic cleavage of protein kinase Cσ is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J Neurosci 2002;22:1738-51. (Pubitemid 35386292)
37. Frutos S, Moscat J, Diaz-Meco MT. Cleavage of ζPKC but not λ/IPKC by caspase-3 during UV-induced apoptosis. J Biol Chem 1999;274:10765-70. (Pubitemid 129528275)
38. Kikuchi H, Imajoh-Ohmi S, Kanegasaki S. Novel antibodies specific for proteolyzed forms of protein kinase C: production of anti-peptide antibodies available for in situ analysis of intracellular limited proteolysis. Biochim Biophys Acta 1993;1162:171-6.
39. Campbell CS, Caperuto LC, Hirata AE, et al. The phosphatidylinositol/ AKT/atypical PKC pathway is involved in the improved insulin sensitivity by DHEA in muscle and liver of rats in vivo. Life Sci 2004;76:57-70.
40. Liu YF, Paz K, Herschkovitz A, et al. Insulin stimulates PKCæ- mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem 2001;276:14459-65.
41. Cecconi D, Zamo A, Bianchi E, et al. Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study. Proteomics 2008;8:4495-506.
42. Frey RS, Gao X, Javaid K, Siddiqui SS, Rahman A, Malik AB. Phosphatidylinositol 3-kinase γ signaling through protein kinase Cζ induces NADPH oxidase-mediated oxidant generation and NF-κB activation in endothelial cells. J Biol Chem 2006;281:16128-38.
43. Liu Y, Wang B, Wang J, et al. Down-regulation of PKCζ expression inhibits chemotaxis signal transduction in human lung cancer cells. Lung Cancer 2009;63:210-8.
44. Patrone C, Ma ZQ, Pollio G, Agrati P, Parker MG, Maggi A. Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Mol Endocrinol 1996;10:499-507.
45. Mizukami Y, Kobayashi S, Uberall F, Hellbert K, Kobayashi N, Yoshida K. Nuclear mitogen-activated protein kinase activation by protein kinase cζ during reoxygenation after ischemic hypoxia. J Biol Chem 2000;275:19921-7.
46. Park IC, Park MJ, Rhee CH, et al. Protein kinase C activation by PMA rapidly induces apoptosis through caspase-3/CPP32 and serine protease(s) in a gastric cancer cell line. Int J Oncol 2001;18: 1077-83.
47. Lai JM, Hsieh CL, Chang ZF. Caspase activation during phorbol ester-induced apoptosis requires ROCK-dependent myosinmediated contraction. J Cell Sci 2003;116:3491-501.
48. Tsao SW, Mok SC, Fey EG, et al. Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res 1995;218:499-507.
49. Papageorgio C, Perry MC. Epidermal growth factor receptor-targeted therapy for pancreatic cancer. Cancer Invest 2007;25: 647-57.
50. Willett CG, Duda DG, Czito BG, Bendell JC, Clark JW, Jain RK. Targeted therapy in rectal cancer. Oncology (Williston Park) 2007; 21:1055-65.
51. Rosell R, Cuello M, Cecere F, et al. Treatment of non-small-cell lung cancer and pharmacogenomics: Where we are and where we are going. Curr Opin Oncol 2006;18:135-43.
52. De Marinis F, Nelli F, D'Auria G. EGFR inhibitors: clinical results. Suppl Tumori 2002;1:S5-6.
53. Blank SV, Chang R, Muggia F. Epidermal growth factor receptor inhibitors for the treatment of epithelial ovarian cancer. Oncology (Williston Park) 2005;19:553-9.
54. Zheng X, Jiang F, Katakowski M, Zhang ZG, Lu QE, Chopp M. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation. Cancer Biol Ther 2009;8.
55. Demers MJ, Thibodeau S, Noel D, et al. Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1. J Cell Biochem 2009;107:639-54.
56. Hashigasako A, Machide M, Nakamura T, Matsumoto K, Nakamura T. Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J Biol Chem 2004;279:26445-52.
57. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998;281:2042-5.
58. Zhang D, Kanthasamy A, Yang Y, Anantharam V, Kanthasamy A. Protein kinase C δ negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. J Neurosci 2007;27:5349-62.
59. Chu CS, Kim SH, June CH, Coukos G. Immunotherapy opportunities in ovarian cancer. Expert Rev Anticancer Ther 2008;8:243-57.
60. Reibenwein J, Krainer M. Targeting signaling pathways in ovarian cancer. Expert Opin Ther Targets 2008;12:353-65.
61. Xin M, Gao F, May WS, Flagg T, Deng X. Protein kinase Cζ abrogates the proapoptotic function of Bax through phosphorylation. J Biol Chem 2007;282:21268-77.
62. Ghosh S, Marquardt T, Thaler JP, et al. Instructive role of aPKCζ subcellular localization in the assembly of adherens junctions in neural progenitors. Proc Natl Acad Sci U S A 2008;105:335-40.
63. Wolf AM, Lyuksyutova AI, Fenstermaker AG, Shafer B, Lo CG, Zou Y. Phosphatidylinositol-3-kinase-atypical protein kinase C signaling is required for Wnt attraction and anterior-posterior axon guidance. J Neurosci 2008;28:3456-67.
64. Galvez AS, Duran A, Linares JF, et al. Protein kinase Cζ represses the interleukin-6 promoter and impairs tumorigenesis in vivo. Mol Cell Biol 2009;29:104-15.
65. Crijns AP, Duiker EW, de Jong S, Willemse PH, van der Zee AG, de Vries EG. Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy. Int J Gynecol Cancer 2006;16 Suppl 1: 152-65.
66. Schultz A, Jonsson JI, Larsson C. The regulatory domain of protein kinase Cτ localises to the Golgi complex and induces apoptosis in neuroblastoma and Jurkat cells. Cell Death Differ 2003;10:662-75.
67. Grifoni D, Garoia F, Bellosta P, et al. aPKCζ cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia. Oncogene 2007;26:5960-5.
68. Sasaki K, Murata M, Yasumoto T, Mieskes G, Takai A. Affinity of okadaic acid to type-1 and type-2A protein phosphatases is markedly reduced by oxidation of its 27-hydroxyl group. Biochem J 1994;298:259-62.
69. Brewis ND, Street AJ, Prescott AR, Cohen PT. PPX, a novel protein serine/threonine phosphatase localized to centrosomes. EMBO J 1993;12:987-96.
70. Cohen PT, Chen MX, Armstrong CG. Novel protein phosphatases that may participate in cell signaling. Adv Pharmacol 1996;36:67-89.
71. Bastians H, Ponstingl H. The novel human protein serine/threonine phosphatase 6 is a functional homologue of budding yeast Sit4p and fission yeast ppe1, which are involved in cell cycle regulation. J Cell Sci 1996;109:2865-74. (Pubitemid 27029257)
72. Huang S, Shu L, Easton J, et al. Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity. J Biol Chem 2004; 279:36490-6.